C1 esterase inhibitor recombinant Intravenous and Omadacycline Tosylate
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Omadacycline Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Omalizumab
- C1 esterase inhibitor recombinant Intravenous-Omalizumab Subcutaneous
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, and Ritonavir
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omadacycline Tosylate-C1 esterase inhibitor, human Intravenous
- Omadacycline Tosylate-C1 Inhibitor (Human)
- Omadacycline Tosylate-C1 Inhibitor (Human) (Berinert)
- Omadacycline Tosylate-C1 Inhibitor (Human) (Cinryze)
- Omadacycline Tosylate-C1 Inhibitor (Human) (Haegarda)
- Omadacycline Tosylate-C1 Inhibitor (Recombinant)